Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50,495,188
-
Total 13F shares
-
44,639,604
-
Share change
-
+1,524,518
-
Total reported value
-
$8,785,487,237
-
Put/Call ratio
-
47%
-
Price per share
-
$196.80
-
Number of holders
-
554
-
Value change
-
+$296,115,460
-
Number of buys
-
282
-
Number of sells
-
287
Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q3 2022
As of 30 Sep 2022 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) had 554 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 44,639,604 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, STATE STREET CORP, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, Clearbridge Investments, LLC, Invesco Ltd., GEODE CAPITAL MANAGEMENT, LLC, Allspring Global Investments Holdings, LLC, Jackson Square Partners, LLC, and FMR LLC.
This table shows 560 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.